{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:46:51Z","timestamp":1783975611616,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.pcd.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T11:26:25Z","timestamp":1756207585000},"page":"613-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adherence to gout treatment guidelines in patients with diabetes: A Danish prospective cohort study with 4 years of follow-up"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-8447","authenticated-orcid":false,"given":"Claus","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3794-0942","authenticated-orcid":false,"given":"Jesper Walther","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2822-9813","authenticated-orcid":false,"given":"Peter Clement Waldhauer","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8314-0608","authenticated-orcid":false,"given":"S\u00f8ren Terpager","family":"Jepsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar Lauge","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2025.08.006_bib1","unstructured":"International Diabetes Federation. IDF Diabetes Atlas. Available from \u3008https:\/\/diabetesatlas.org\u3009. Accessed 24 July 2024."},{"key":"10.1016\/j.pcd.2025.08.006_bib2","unstructured":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Ong, Kanyin Liane et al. The Lancet, Volume 402, Issue 10397, 203 \u2013 234."},{"key":"10.1016\/j.pcd.2025.08.006_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.diabres.2007.01.010","article-title":"Incidence of critical limb ischaemia and amputation outcome in contralateral limb in diabetes patients hospitalized for unilateral critical limb ischemia during 1999\u20132003 and followed-up until 2005","volume":"77","author":"Faglia","year":"2007","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.pcd.2025.08.006_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.diabres.2017.05.025","article-title":"Decreasing incidence of foot ulcer among patients with type 1 and type 2 diabetes in the period 2001-2014","volume":"130","author":"Rasmussen","year":"2017","journal-title":"Diabetes Res Clin. Pr."},{"issue":"12","key":"10.1016\/j.pcd.2025.08.006_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294813","article-title":"Associations between specialty care and improved outcomes among patients with diabetic foot ulcers","volume":"18","author":"Liu","year":"2023","journal-title":"PloS ONE"},{"key":"10.1016\/j.pcd.2025.08.006_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001358","article-title":"Individuals with type 2 diabetes mellitus are at an increased risk of gout but this is not due to diabetes: a population-based cohort study","volume":"94","author":"Wijnands","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.pcd.2025.08.006_bib7","article-title":"Patients with severe gout treated in mixed settings","volume":"68","author":"Rasmussen","year":"2021","journal-title":"Dan. Med J."},{"key":"10.1016\/j.pcd.2025.08.006_bib8","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.amjmed.2010.03.027","article-title":"Serum uric acid levels and the risk of type 2 diabetes: a prospective study","volume":"123","author":"Bhole","year":"2010","journal-title":"Am. J. Med"},{"key":"10.1016\/j.pcd.2025.08.006_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/rheumatology\/key390","article-title":"Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based study","volume":"58","author":"Zobbe","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.pcd.2025.08.006_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.pcd.2025.08.006_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.42347","article-title":"Comparison of rates of lower extremity amputation in patients with and without gout in the US department of veterans affairs health system","volume":"5","author":"Mikuls","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.pcd.2025.08.006_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.30885","article-title":"Gout flares and mortality after Sodium-Glucose Cotransporter-2 inhibitor treatment for gout and type 2 diabetes","volume":"6","author":"Wei","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.pcd.2025.08.006_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2474-11-98","article-title":"The prevalence of rheumatic diseases in central Greece: a population survey","volume":"11","author":"Anagnostopoulos","year":"2010","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.pcd.2025.08.006_bib14","first-page":"43","article-title":"High prevalence of gout in patients with type 2 diabetes: Male sex, renal impairment, and diuretic use are major risk factors","volume":"121","author":"Suppiah","year":"2008","journal-title":"N. Z. Med J."},{"key":"10.1016\/j.pcd.2025.08.006_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004179","article-title":"Optimising gout treatment: insights from a nurse-led cohort study","volume":"10","author":"Rasmussen","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.pcd.2025.08.006_bib16","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pcd.2025.08.006_bib17","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/acr.25380","article-title":"Adherence and treat-to-target benchmarks in older adults with gout initiating urate-lowering therapy in ontario, Canada: a population-based study","volume":"76","author":"Kwok","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.pcd.2025.08.006_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2021.105257","article-title":"Prevalence of gout in the adult general population in Spain: estimating the proportion of undiagnosed cases","volume":"89","author":"Quilis","year":"2022","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.pcd.2025.08.006_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.15277\/bjdvd.2014.004","article-title":"Ulcerated gout masquerading as a non-healing diabetic foot ulcer: a case series","volume":"14","author":"Crasto","year":"2014","journal-title":"Br. J. Diabetes Vasc. Dis."},{"issue":"1","key":"10.1016\/j.pcd.2025.08.006_bib20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/wrr.12973","article-title":"Gout-associated uric acid crystals induce tophi ulcerations and impair wound healing in a novel gouty ulcer model","volume":"30","author":"Bao","year":"2022","journal-title":"Wound Rep. Reg."},{"key":"10.1016\/j.pcd.2025.08.006_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.pcd.2025.08.006_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/art.10511","article-title":"Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.pcd.2025.08.006_bib23","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s11606-017-4233-5","article-title":"Effects of discontinuation of urate-lowering therapy: a systematic review","volume":"33","author":"Beslon","year":"2018","journal-title":"J. Gen. Intern Med"},{"key":"10.1016\/j.pcd.2025.08.006_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13075-016-1211-y","article-title":"Factors associated with initiation and persistence of urate-lowering therapy","volume":"19","author":"Dehlin","year":"2017","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.pcd.2025.08.006_sbref23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.semarthrit.2017.09.007","article-title":"Medication adherence among patients with gout: a systematic review and meta-analysis","volume":"47","author":"Scheepers","year":"2018","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.pcd.2025.08.006_sbref24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"2018 updated european league against rheumatism evidence-based recommendations for the diagnosis of gout","volume":"79","author":"Richette","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":". 1","key":"10.1016\/j.pcd.2025.08.006_bib26","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.2337\/dc24-S004","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2025.08.006_bib27","doi-asserted-by":"crossref","DOI":"10.2337\/cd24-0082","article-title":"Gout: an overlooked disease in patients with diabetes? A danish prospective cohort study with 2 years of Follow-Up","author":"Rasmussen","year":"2025","journal-title":"Clin. Diabetes"},{"key":"10.1016\/j.pcd.2025.08.006_bib28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","article-title":"Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study","volume":"72","author":"Rees","year":"2013","journal-title":"Ann. Rheum. Dis. Vol."},{"key":"10.1016\/j.pcd.2025.08.006_bib29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jama.2022.11390","article-title":"Association between gout flare and subsequent cardiovascular events among patients with gout","volume":"328","author":"Cipolletta","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.pcd.2025.08.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RHU.0b013e318204a8f9","article-title":"The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach","volume":"17","author":"Lindsay","year":"2011","journal-title":"J. Clin. Rheuma"},{"key":"10.1016\/j.pcd.2025.08.006_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-092522","article-title":"Allopurinol use and risk of acute coronary syndrome in gout patients: a population-based cohort study in Sweden","volume":"15","author":"Drivelegka","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.pcd.2025.08.006_bib32","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2665-9913(21)00319-2","article-title":"Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials","volume":"4","author":"Stamp","year":"2022","journal-title":"Lancet Rheuma"},{"key":"10.1016\/j.pcd.2025.08.006_bib33","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1002\/art.30649","article-title":"A two-stage approach to the treatment of hyperuricemia in gout: the \u201cdirty dish\u201d hypothesis","volume":"63","author":"Perez-Ruiz","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.pcd.2025.08.006_bib34","article-title":"Identifying tophaceous gout in foot ulcers using ulcer debris microscopy in type 2 diabetes","volume":"26","author":"Rasmussen","year":"2025","journal-title":"J. Wound Manag."},{"key":"10.1016\/j.pcd.2025.08.006_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/iwj.12262","article-title":"Clinical characteristics of foot ulceration in people with chronic gout","volume":"13","author":"Rome","year":"2016","journal-title":"Int Wound J."},{"key":"10.1016\/j.pcd.2025.08.006_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4997\/jrcpe.2019.412","article-title":"Chronic tophaceous gout presenting as nonhealing ulcers","volume":"49","author":"Jadhav","year":"2019","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"10.1016\/j.pcd.2025.08.006_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.ASW.0000515456.65405.56","article-title":"Nonhealing ulcers in patients with tophaceous gout: a systematic review","volume":"30","author":"Lam","year":"2017","journal-title":"Adv. Ski. Wound Care"},{"key":"10.1016\/j.pcd.2025.08.006_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3657","article-title":"Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update)","volume":"40","author":"Schaper","year":"2024","journal-title":"Diabetes Metab. Res Rev."},{"key":"10.1016\/j.pcd.2025.08.006_bib39","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1136\/annrheumdis-2012-201687","article-title":"Gout: why is this curable disease so seldom cured?","volume":"71","author":"Doherty","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.pcd.2025.08.006_bib40","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/art.30119","article-title":"Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment","volume":"63","author":"Stamp","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.pcd.2025.08.006_bib41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3904\/kjim.2018.205","article-title":"Clinical features and recurrent attack in gout patients according to serum urate levels during an acute attack","volume":"35","author":"Lee","year":"2020","journal-title":"Korean J. Intern Med"},{"key":"10.1016\/j.pcd.2025.08.006_bib42","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/ard-2023-224771","article-title":"2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice","volume":"83","author":"Mandl","year":"2024","journal-title":"Ann. Rheum. Dis."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991825001561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991825001561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:22:47Z","timestamp":1763698967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991825001561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1751991825001561"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2025.08.006","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to gout treatment guidelines in patients with diabetes: A Danish prospective cohort study with 4 years of follow-up","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2025.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.","name":"copyright","label":"Copyright"}]}}